Alex Barrett, PhD
Denver, Colorado, United States
1K followers
500+ connections
About
I am a health AI and molecular oncology expert with 10+ years experience specializing on…
Activity
-
This is a big deal. Tempus AI receives the first CPT code created to describe an algorithm-only analysis from a previously sequenced laboratory…
This is a big deal. Tempus AI receives the first CPT code created to describe an algorithm-only analysis from a previously sequenced laboratory…
Liked by Alex Barrett, PhD
-
When Brianne Brennan was 6, she spent a lot of time at doctor’s appointments with her older brother, Travis. Although she did not fully understand…
When Brianne Brennan was 6, she spent a lot of time at doctor’s appointments with her older brother, Travis. Although she did not fully understand…
Liked by Alex Barrett, PhD
-
TrIHealth Precision Oncology team received recognition for AI application utilizing TempusNext to address care gaps in cancer care. This…
TrIHealth Precision Oncology team received recognition for AI application utilizing TempusNext to address care gaps in cancer care. This…
Liked by Alex Barrett, PhD
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
Licenses & Certifications
Publications
-
Method and process for predicting and analyzing patient cohort response, progression, and survival
US Patent
See publicationA system and method for analyzing a data store of de-identified patient data to generate one or more dynamic user interfaces usable to predict an expected response of a particular patient population or cohort when provided with a certain treatment. The automated analysis of patterns occurring in patient clinical, molecular, phenotypic, and response data, as facilitated by the various user interfaces, provides an efficient, intuitive way for clinicians to evaluate large data sets to aid in the…
A system and method for analyzing a data store of de-identified patient data to generate one or more dynamic user interfaces usable to predict an expected response of a particular patient population or cohort when provided with a certain treatment. The automated analysis of patterns occurring in patient clinical, molecular, phenotypic, and response data, as facilitated by the various user interfaces, provides an efficient, intuitive way for clinicians to evaluate large data sets to aid in the potential discovery of insights of therapeutic significance.
-
Compartment resolved proteomics reveals a dynamic matrisome in a biomechanically driven model of pancreatic ductal adenocarcinoma
Journal of Immunology and Regenerative Medicine
-
Quantitative extracellular matrix proteomics to study breast cancer microenvironment
International Journal of Biochemistry & Cell Biology
Courses
-
Biophysics and Spectroscopy
-
-
Cancer Biology
-
-
Chemical Biology
-
-
Epidemiology
-
-
Mass Spectrometry & Proteomics
-
-
Medicinal Chemistry
-
-
Molecular Interactions
-
-
Molecular Interactions
-
-
Structural Biology
-
-
Tissue Biology and Disease Mechanisms
-
Projects
-
Structural Basis for ternary complex between tau, Hsp90, and FKBP51
-
See projectThis project involves studying the structural and thermodynamic interaction between a group of Alzheimer's disease related proteins using nuclear magnetic resonance (NMR) spectroscopy and isothermal titration calorimetry (ITC) techniques.
Honors & Awards
-
Best Poster (Oncology)
University of Colorado Anschutz Medical Campus Student Research Forum
"Characterizing solid tumor fibrosis using targeted proteomics and cross-linking analysis"
-
Selected Oral Presentation
American Society for Matrix Biology
“Targeted proteomics and cross-linking analysis reveal alterations in the microenvironment of pancreatic tumors”
-
Structural Biology and Biochemistry Travel Award
-
-
Colorado Clinical and Translational Sciences Institute Pre-Doctoral Fellowship
-
Colorado Clinical and Translational Sciences Institute, National Institutes of Health
More activity by Alex
-
We are excited to present a unique synergistic offering from Tempus Biological Modeling to accelerate your Oncology drug development programs. It…
We are excited to present a unique synergistic offering from Tempus Biological Modeling to accelerate your Oncology drug development programs. It…
Liked by Alex Barrett, PhD
-
This post is intended for a US audience. We’re just a few weeks past AstraZeneca’s history-making appearance at ASCO with the #ADRIATIC study in…
This post is intended for a US audience. We’re just a few weeks past AstraZeneca’s history-making appearance at ASCO with the #ADRIATIC study in…
Liked by Alex Barrett, PhD
-
It is hard to believe how far we have come since Tempus first participated in ASCO over 8 years ago. Proud of this team as we evolve and expand our…
It is hard to believe how far we have come since Tempus first participated in ASCO over 8 years ago. Proud of this team as we evolve and expand our…
Liked by Alex Barrett, PhD
-
This post is intended for a US audience: To say we had high hopes for today’s #ASCO24 DOUBLE plenary session featuring back-to-back Phase III trials…
This post is intended for a US audience: To say we had high hopes for today’s #ASCO24 DOUBLE plenary session featuring back-to-back Phase III trials…
Liked by Alex Barrett, PhD
-
Extremely excited to share this study which shows clinical efficacy of using a JAK inhibitor with checkpoint blockade. By targeting chronic…
Extremely excited to share this study which shows clinical efficacy of using a JAK inhibitor with checkpoint blockade. By targeting chronic…
Liked by Alex Barrett, PhD
-
This week my colleagues and I visited the AstraZeneca Hope Lodge in Boston, a place offering a free home away from home for #cancer patients and…
This week my colleagues and I visited the AstraZeneca Hope Lodge in Boston, a place offering a free home away from home for #cancer patients and…
Liked by Alex Barrett, PhD
-
We’re thrilled to announce that we have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for our ECG-AF device that uses AI…
We’re thrilled to announce that we have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for our ECG-AF device that uses AI…
Liked by Alex Barrett, PhD
-
AI is a learning system and our goal is to harness its capabilities in healthcare to translate the experience of patients in the past to the care of…
AI is a learning system and our goal is to harness its capabilities in healthcare to translate the experience of patients in the past to the care of…
Liked by Alex Barrett, PhD
-
This content is for US audiences only. The relentless pace of oncology innovation never slows down – even after AstraZeneca’s thrilling ASCO…
This content is for US audiences only. The relentless pace of oncology innovation never slows down – even after AstraZeneca’s thrilling ASCO…
Liked by Alex Barrett, PhD
-
It’s one of the greatest honors of my career to work with the team at AstraZeneca to use AI to make guideline-directed available to all patients…
It’s one of the greatest honors of my career to work with the team at AstraZeneca to use AI to make guideline-directed available to all patients…
Liked by Alex Barrett, PhD
-
Congratulations to the people of #TempusAI for another important milestone in their efforts to shape the modern practice of #oncology and improve…
Congratulations to the people of #TempusAI for another important milestone in their efforts to shape the modern practice of #oncology and improve…
Liked by Alex Barrett, PhD
-
🎉 Welcome to the Nasdaq family, Tempus AI! 🎉 🤖 $TEM harnesses the power of data and AI to drive precision medicine forward. Now they’re…
🎉 Welcome to the Nasdaq family, Tempus AI! 🎉 🤖 $TEM harnesses the power of data and AI to drive precision medicine forward. Now they’re…
Liked by Alex Barrett, PhD
-
Thank you to all of our patients and physician and research partners for your collective commitment to our mission of improving patient outcomes…
Thank you to all of our patients and physician and research partners for your collective commitment to our mission of improving patient outcomes…
Liked by Alex Barrett, PhD
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Alex Barrett, PhD
1 other named Alex Barrett, PhD is on LinkedIn
See others named Alex Barrett, PhD